Skip to main content

Advertisement

SpringerLink
Log in

Study on the dose modification factor of strut adjusted volume implant (SAVI) with a 169Yb source using MCNP4C

  • Scientific Paper
  • Published:
Australasian Physical & Engineering Sciences in Medicine Aims and scope Submit manuscript

Abstract

The SAVI has gained widespread use for accelerated partial breast irradiation (APBI) brachytherapy. Treatments with SAVI produce inherent heterogeneities including variable backscatter due to proximity to the tissue-air interface and variable cavity contents, causing inaccuracy in the dose calculation. In this study, a model of SAVI with sources of 169Yb developed recently was defined and simulations with MCNP4C code of Monte Carlo were performed through different scenarios to assess the effects of these heterogeneities on the dose distribution. The results showed that the dose delivered to target volume may be lower than the planned dose by up to 9–16%. Therefore, the therapy with169Yb must be viewed with caution and a correction factor must be applied in treatment planning systems. It was also observed that the presence of air cavity changed the relative dose 1% for a symmetric plan compared to a water cavity and up to 5% for an asymmetric plan. It was indicated that the dose modification factor (DMF) did not differ in any significant way to that of the symmetric plan. The effect of the composition on the DMF was negligible because the natures of water and breast tissue were approximately similar. All the obtained results indicated that should 169Yb sources be used with SAVI applications, some amendments of treatment planning systems would be employed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

References

  1. http://www.cancer.org/cancer/breastcancer/detailedguide/breast-cancer-treating-by-stage. Accessed 02 Mar 2017

  2. Fisher B, Anderson S, Bryant J, Margolese RG, Deutsch M, Fisher ER, Jeong J-H, Wolmark N (2002) Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 347(16):1233–1241

    Article  PubMed  Google Scholar 

  3. Holli K, Saaristo R, Isola J, Joensuu H, Hakama M (2001) Lumpectomy with or without postoperative radiotherapy for breast cancer with favourable prognostic features: results of a randomized study. B J Cancer 84(2):164

    Article  CAS  Google Scholar 

  4. Veronesi U, Cascinelli N, Mariani L, Greco M, Saccozzi R, Luini A, Aguilar M, Marubini E (2002) Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 347(16):1227–1232

    Article  PubMed  Google Scholar 

  5. Kuerer HM, Julian TB, Strom EA, Lyerly HK, Giuliano AE, Mamounas EP, Vicini FA (2004) Accelerated partial breast irradiation after conservative surgery for breast cancer. Ann Surg 239(3):338–351

    Article  PubMed  PubMed Central  Google Scholar 

  6. Scanderbeg DJ, Yashar C, Rice R, Pawlicki T (2009) Clinical implementation of a new HDR brachytherapy device for partial breast irradiation. Radiother Oncol 90(1):36–42

    Article  PubMed  Google Scholar 

  7. Yashar CM, Scanderbeg D, Kuske R, Wallace A, Zannis V, Blair S, Grade E, Swenson VH, Quiet C (2011) Initial clinical experience with the strut-adjusted volume implant (SAVI) breast brachytherapy device for accelerated partial-breast irradiation (APBI): first 100 patients with more than 1 year of follow-up. Int J Radiat Oncol Biol Phys 80(3):765–770

    Article  PubMed  Google Scholar 

  8. Richardson SL, Pino R (2010) Dosimetric effects of an air cavity for the SAVI™ partial breast irradiation applicator. Med Phys 37(8):3919–3926

    Article  PubMed  Google Scholar 

  9. Park S, DeMarco J, Kamrava M, Demanes D, Low D (2011) SU-E-T-380: evaluation of interfraction motion of the strut-adjusted volume implant (SAVI) using 3D reconstruction from CT scout images. Med Phys 38(6):3575–3575

    Article  Google Scholar 

  10. Gurdalli S, Kuske RR, Quiet CA, Ozer M (2011) Dosimetric performance of strut-adjusted volume implant: a new single-entry multicatheter breast brachytherapy applicator. Brachytherapy 10(2):128–135

    Article  PubMed  Google Scholar 

  11. Pearson D, Williams EA (2013) Dose modification factor analysis of multilumen balloon brachytherapy applicator with Monte Carlo simulation. J Appl Clin Med Phys 15(3):54–62

    Article  PubMed  PubMed Central  Google Scholar 

  12. Rivard MJ, Coursey BM, DeWerd LA, Hanson WF, Hug MS, Ibbott GS, Mitch MG, Nath R, Williamson JF (2004) Update of AAPM task group no. 43 report: a revised AAPM protocol for brachytherapy dose calculations. Med Phys 31(3):633–674

    Article  PubMed  Google Scholar 

  13. Beaulieu L, Carlsson Tedgren A, Carrier JF, Davis SD, Mourtada F, Rivard MJ, Thomson RM, Verhaegen F, Wareing TA, Williamson JF (2012) Report of the task group 186 on model-based dose calculation methods in brachytherapy beyond the TG-43 formalism: current status and recommendations for clinical implementation. Med Phys 39(10):6208–6236

    Article  PubMed  Google Scholar 

  14. Medich DC, Tries MA, Munro JJ (2006) Monte Carlo characterization of an ytterbium-169 high dose rate brachytherapy source with analysis of statistical uncertainty. Med Phys 33:163–172

    Article  PubMed  CAS  Google Scholar 

  15. Granero D, Pèrez-Calatayud J, Ballester F, Bos AJJ, Venselaar J (2006) Broad-beam transmission data for new brachytherapy sources, Tm-170 and Yb-169. Radiat Prot Dosim 118:11–15

    Article  CAS  Google Scholar 

  16. Lymperopoulou G, Papagiannis P, Sakelliou L, Georgiou E, Hourdakis CJ, Baltas D (2006) Comparison of radiation shielding requirements for HDR brachytherapy using 169Yb and 192Ir sources. Med Phys 33:2541–2547

    Article  PubMed  CAS  Google Scholar 

  17. Lymperopoulou G, Papagiannis P, Angelopoulos A, Karaiskos P, Georgiou E, Baltas D (2006) A dosimetric comparison of 169Yb and 192Ir for HDR brachytherapy of the breast, accounting for the effect of finite patient dimensions and tissue inhomogeneities. Medical physics 33(12):4583–4589

    Article  PubMed  CAS  Google Scholar 

  18. Papagiannis P, Karaiskos P, Georgiou E, Baltas D, Lymperopoulou G, Pantelis E, Sakelliou L (2007) On the use of high dose rate Ir192 and Yb169 sources with the MammoSite® radiation therapy system. Med Phys 34(9):3614–3619

    Article  CAS  PubMed  Google Scholar 

  19. Saxena SK, Kumar Y, Jagadeesan K, Nuwad J, Bamankar Y, Dash A (2015) Studies on the development of 169 Yb-brachytherapy seeds: new generation brachytherapy sources for the management of cancer. Appl Radiat Isot 101:75–82

    Article  PubMed  CAS  Google Scholar 

  20. Shultis JK, Faw RE (2011) An MCNP primer. Kansas State University, Manhattan

    Google Scholar 

  21. Kocher DC (1981) Radioactive decay tables-A handbook of decay data for application to radiation dosimetry and radiological assessment. Department of Energy (DOE)/Technical Information Center (TIC), Springfield

    Google Scholar 

  22. Woodard HQ, White DR (1986) The composition of body tissues. Br J Radiol 59(708):1209–1218

    Article  PubMed  CAS  Google Scholar 

  23. Williams E (2012) Dose modification factor analysis of multi-lumen brachytherapy applicator with Monte Carlo simulation. Dissertation, University of Toledo

  24. Sherman JR (2011) The comparison of dose modification factors for two multi-lumen brachytherapy applicators used in partial breast irradiation. Dissertation, University of Toledo

Download references

Author information

Authors and Affiliations

  1. Department of Energy Engineering and Physics, Amirkabir University of Technology, 424 Hafez Ave, Tehran, Iran

    Seyed Milad Vahabi, Mostean Bahreinipour & Mojtaba Shamsaie Zafarghandi

Authors
  1. Seyed Milad Vahabi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mostean Bahreinipour
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mojtaba Shamsaie Zafarghandi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mostean Bahreinipour.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

This article does not contain any studies with human participants or animals performed by any of the authors.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Vahabi, S.M., Bahreinipour, M. & Shamsaie Zafarghandi, M. Study on the dose modification factor of strut adjusted volume implant (SAVI) with a 169Yb source using MCNP4C. Australas Phys Eng Sci Med 41, 445–450 (2018). https://doi.org/10.1007/s13246-018-0641-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13246-018-0641-z

Keywords

Search

Navigation